11 July 2025 · Data exclusivity and market protection periods prevent generic or biosimilar competition for at least 10 years after the originator medicine is licensed.
11 July 2025 · Patents allow the inventor a finite period of monopoly in exchange for publicising the idea. We explain how they work with respect to medicines.
11 July 2025 · New medicines have several protections against competition. Other factors influence availability of generics or biosimilars after loss of exclusivity.
9 July 2025 · Cutting or masking transdermal patches is discouraged. Matrix patches can be cut if no licensed alternatives are available; reservoir patches should not be cut.
9 July 2025 · Practical guidance for safe application, monitoring, removal, disposal, documentation and storage of transdermal patches to reduce risk of medication errors.
8 July 2025 · Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration